Numinus Licencing Amendment: We Speak to the Team

by Aya Gonzalez

Jun 12, 2020

Numinus Chief Operating Officer Michael Tan explains what the company’s recent Health Canada licence amendment, which will allow them to produce and extract psilocybin from mushrooms, means for upcoming research.

Click here to read the full article.

We want to connect with you!

Sign up here so we can keep in touch.